Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer

Up to now, the efficacy of programmed death protein 1/programmed death ligand 1 (PD-1/PD-L1) blockade in pancreatic cancer (PC) remains uncertain. Serum levels of soluble PD-1 and PD-L1 (sPD-1/sPD-L1) have been reported to be independent prognostic factors in solid tumors susceptible to checkpoint b...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncoimmunology
Päätekijät: Kruger, Stephan, Legenstein, Marie-Louise, Rösgen, Verena, Haas, Michael, Modest, Dominik Paul, Westphalen, Christoph Benedikt, Ormanns, Steffen, Kirchner, Thomas, Heinemann, Volker, Holdenrieder, Stefan, Boeck, Stefan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2017
Aiheet:
Brief Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5467983/
https://ncbi.nlm.nih.gov/pubmed/28638732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1310358
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia